ANN ARBOR — Esperion Therapeutics Inc. Monday announced the start of a Phase 3 study to assess the safety and efficacy of a combination pill containing its cholesterol-fighter, bempedoic acid, with ezetimibe, a drug that decreases cholesterol absorption in the small intestine. Ezetimibe is used when other cholesterol-lowering medications, such as statins, are not tolerated
GRAND RAPIDS – Behavoral health patients benefit from better care coordination when their health providers leverage a reversed shared care approach supported by Great Lakes Health Connect’s referrals application. Closing the gap in communication between behavioral health and primary care providers was the foundation of Lara Dengerink-VanTil’s doctoral dissertation as part of her Doctorate in
ANN ARBOR - Aquaro Histology announced Thursday it has completed a $9.8 million Series A round led by Telegraph Hills Partners. Aquaro, formerly known as Aquaro Biosystems, will use the money to launch its first product, an Automated Section Mounting used in medical research and development. Concurrent with the financing, Tom Raffin, M.D.; Deval Lashkari,
ANN ARBOR - Genomenon has announced that it will begin offering a free edition of the Mastermind Genomic Search Engine to clinical, research and academic institutions to advance genomic analysis and DNA data interpretation. Genomenon is making Mastermind freely available to promote more rapid advances in genome analysis and DNA sequencing interpretation. Mastermind is a
MOUNT PLEASANT - A new cooperative agreement will grant Grand Valley State University premedical students early assurance of admission to the Central Michigan University College of Medicine through the Early Assurance Program. The agreement — signed by GVSU President Dr. Thomas Hass and CMU President Dr. George Ross on October 19 in a formal ceremony
ANN ARBOR - An injury pathway in the neurons of fruit flies may cause the loss of synapses in diseases such as Alzheimer's and ALS, according to University of Michigan researchers. This pathway, called DLK, has received recent attention as a candidate drug target because it contributes to the deterioration of damaged neurons. The new
ANN ARBOR - The University of Michigan has launched a new initiative to harness campus-wide research aimed at finding personalized solutions to improve the health and wellness of individuals and communities. Precision Health at the University of Michigan will bring together researchers from across the university to coordinate this new and exciting type of research.
ANN ARBOR - Ten years from now, Americans born in 1960 will be able to start collecting their full Social Security retirement check, at the age of 67. That's two years later than their parents, because of a change in the federal retirement age enacted in 1983. But a new study shows that today's pre-retirement
GRAND RAPIDS - The monthly Health Forum of West Michigan series begins its new year with a panel discussion that focuses on the supply and demand of health care jobs, and how area higher education institutions are working to meet the needs of industry employers and employees. "The Health Care Talent Pipeline" is set for
ANN ARBOR - A technology that can print pure, ultra-precise doses of drugs onto a wide variety of surfaces could one day enable on-site printing of custom-dosed medications at pharmacies, hospitals and other locations. The technique, which was developed at the University of Michigan, can print multiple medications into a single dose on a dissolvable
